U.S. FDA’s Response To Heparin Scare Made With “Alacrity And Sound Judgment” – von Eschenbach

In a Feb. 15 e-mail to agency personnel, U.S. FDA Commissioner Andrew von Eschenbach said the U.S. FDA has responded to the recent import safety scare related to Baxter Healthcare's injectable heparin "with its customary alacrity and sound judgment.

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip